Iron polymaltose Active Not Recruiting Phase 4 Trials for Renal Anemia / Iron Toxicity / Stress Oxidative / Endothelial Dysfunction Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03388385Acute Effects of Intravenous Iron on Oxidative Stress and Endothelial Dysfunction in Non-dialysis CKD